| 1 |
Chemotherapy only |
CT |
| 2 |
Chemotherapy + trastuzumab 1 year |
CT + H1y |
| 3 |
Chemotherapy + trastuzumab ≤ 6 months |
CT + H ≤ 6 m |
| 4 |
Chemotherapy → trastuzumab 1 year (sequential to chemotherapy) |
CT-H1y |
| 5 |
Chemotherapy → trastuzumab 2 year (sequential to chemotherapy) |
CT-H2y |
| 6 |
Chemotherapy + trastuzumab 1 year + pertuzumab (concomitant with trastuzumab) |
CT + H + P |
| 7 |
Chemotherapy + lapatinib 1 year |
CT + L |
| 8 |
Chemotherapy + trastuzumab 1 year + lapatinib (concomitant with trastuzumab) |
CT + H + L |
| 9 |
Chemotherapy + trastuzumab 3 months → lapatinib 9 months (sequential to trastuzumab) |
CT + H-L |
| 10 |
Chemotherapy (taxane plus carboplatin) + trastuzumab 1 year |
TC + H |
| 11 |
Chemotherapy + trastuzumab 1 year → neratinib 1 year (sequential to trastuzumab) |
CT + H-N |
